628 related articles for article (PubMed ID: 25445887)
1. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
2. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
3. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
Magira EE; Islam S; Niederman MS
Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study.
Lat I; Daley MJ; Shewale A; Pangrazzi MH; Hammond D; Olsen KM;
Pharmacotherapy; 2019 Mar; 39(3):253-260. PubMed ID: 30101412
[TBL] [Abstract][Full Text] [Related]
5. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
6. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.
Verhamme KM; De Coster W; De Roo L; De Beenhouwer H; Nollet G; Verbeke J; Demeyer I; Jordens P
Infect Control Hosp Epidemiol; 2007 Apr; 28(4):389-97. PubMed ID: 17385143
[TBL] [Abstract][Full Text] [Related]
7. First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.
Ma X; Wu Y; Li L; Xu Q; Hu B; Ni Y; Wu A; Sun S; Jarlier V; Robert J
BMC Infect Dis; 2015 Aug; 15():358. PubMed ID: 26290050
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.
Tumbarello M; De Pascale G; Trecarichi EM; Spanu T; Antonicelli F; Maviglia R; Pennisi MA; Bello G; Antonelli M
Intensive Care Med; 2013 Apr; 39(4):682-92. PubMed ID: 23370828
[TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
10. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
Covington EW; Rufe A
J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
[No Abstract] [Full Text] [Related]
11. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study.
Moine P; Timsit JF; De Lassence A; Troché G; Fosse JP; Alberti C; Cohen Y;
Intensive Care Med; 2002 Feb; 28(2):154-63. PubMed ID: 11907658
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
[TBL] [Abstract][Full Text] [Related]
13. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
Huang X; Li G; Yi L; Li M; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
[TBL] [Abstract][Full Text] [Related]
14. The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods.
Wolfensberger A; Kuster SP; Marchesi M; Zbinden R; Hombach M
Antimicrob Resist Infect Control; 2019; 8():193. PubMed ID: 31798839
[TBL] [Abstract][Full Text] [Related]
15. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
[TBL] [Abstract][Full Text] [Related]
17. Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.
Oster G; Berger A; Edelsberg J; Weber DJ
J Med Econ; 2013; 16(6):809-19. PubMed ID: 23574431
[TBL] [Abstract][Full Text] [Related]
18. Disease burden of intensive care unit-acquired pneumonia in China: a systematic review and meta-analysis.
Zhang Y; Yao Z; Zhan S; Yang Z; Wei D; Zhang J; Li J; Kyaw MH
Int J Infect Dis; 2014 Dec; 29():84-90. PubMed ID: 25449241
[TBL] [Abstract][Full Text] [Related]
19. Can the clinical pulmonary infection score impact ICU antibiotic days?
Swoboda SM; Dixon T; Lipsett PA
Surg Infect (Larchmt); 2006 Aug; 7(4):331-9. PubMed ID: 16978076
[TBL] [Abstract][Full Text] [Related]
20. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
